Pharmacokinetics and Safety of Intravenous Topiramate in Adult Patients

Completed · Phase 1

Conditions studied: Epilepsy, Migraines

In brief

The aims of this study are to determine, in adult patients on maintenance topiramate therapy, the steady-state pharmacokinetics and safety of orally and intravenously administered topiramate.

Key facts

Study ID

NCT00753493

Run by

University of Minnesota

People needed

20

Starts

2008-08-01

Expected to finish

2010-08-01

Last updated by the study team

2019-07-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Persons taking topiramate
• Persons 18 years of age and older

You may not qualify if…

• Patients who are pregnant
• Patients who are breast feeding
• Patients with significant medical problems who may not tolerate intravenous administration
• Patients taking medications known to affect topiramate disposition

Where it is running

• University of Minnesota — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.